Larger is not necessarily better! Impact of HIV care unit characteristics on virological success: results from the French national representative ANRS-VESPA2 study

Health Policy. 2016 Aug;120(8):936-47. doi: 10.1016/j.healthpol.2016.07.003. Epub 2016 Jul 14.

Abstract

Objectives: To determine the impact of hospital caseload size on HIV virological success when taking into account individual patient characteristics.

Methods: Data from the ANRS-VESPA2 survey representative of people living with HIV in France was used. Analyses were carried out on the 2612 (86.4% out of 3022) individuals receiving antiretroviral (ARV) treatment for at least one year. Outcomes correspond to two definitions of virological success (VS1 and VS2 respectively) and were analyzed under a multi-level modeling framework with a special focus on the effect of the caseload size on VS.

Results: Structures with caseloads <1700 patients were more likely to have increased the proportion of patients achieving virological success (59% and 81% for VS1 and VS2, respectively) than structures whose caseloads numbered ≥1700 patients. Our results highlight that patients in the 11 largest care units in the sample were exposed to a context where their VS was potentially compromised by care unit characteristics, independently of both their individual characteristics and their own HIV treatment adherence behavior.

Conclusions: Our results suggest that - at least in the case of HIV care - in France large care units are not necessarily better. This result serves as an evidence-based warning to public authorities to ensure that health outcomes are guaranteed in an era when the French hospital sector is being substantially restructured.

Keywords: HIV clinical outcomes; Hospital merger; caseload size; multi-level modeling.

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Case Management / organization & administration*
  • Female
  • France
  • HIV Infections / drug therapy
  • HIV Infections / psychology*
  • HIV Infections / virology
  • Health Status Indicators
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance
  • Surveys and Questionnaires
  • Treatment Outcome*

Substances

  • Anti-HIV Agents